Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

Background: Alzheimer’s disease (AD) is a complex and severe neurodegenerative disease that still lacks effective methods of diagnosis. The current diagnostic methods of AD rely on cognitive tests, imaging techniques and cerebrospinal fluid (CSF) levels of amyloid-β1-42 (Aβ42), total tau protein and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chun-Hung, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963160/
https://www.ncbi.nlm.nih.gov/pubmed/33803217
http://dx.doi.org/10.3390/ijms22052761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963160/
https://www.ncbi.nlm.nih.gov/pubmed/33803217
http://dx.doi.org/10.3390/ijms22052761

Ejemplares similares